Enteric fever, commonly known as typhoid fever, is a systemic infection caused by Salmonella enterica serotype Typhi or Paratyphi. The disease continues to be a significant health problem in developing countries, especially those with poor sanitation and hygiene. This article aims to provide healthcare professionals with comprehensive strategies for the effective management of enteric fever.
Enteric fever is endemic in areas with poor sanitation and limited access to clean water. It is estimated that each year, there are about 11–20 million cases and approximately 128,000–161,000 typhoid-related deaths worldwide. The clinical features of enteric fever can range from mild, non-specific febrile illness to severe disease with complications such as intestinal perforation, encephalopathy, and multi-organ failure.
Diagnosis of enteric fever can be challenging due to its non-specific clinical features. Blood culture remains the gold standard for diagnosis. However, it has a sensitivity of only 40%-60%. Other diagnostic tests include the Widal test, stool culture, and newer tests like PCR and serological tests. A high index of suspicion is necessary, especially in endemic areas or in patients with a travel history to these areas.
Antimicrobial therapy is the mainstay of treatment for enteric fever. The choice of antimicrobial depends on local susceptibility patterns and the patient's clinical condition. Fluoroquinolones were once the drugs of choice, but resistance has become a significant problem. Currently, third-generation cephalosporins and azithromycin are commonly used. It is crucial to monitor patients for clinical response and adjust therapy as needed.
Complications of enteric fever, such as intestinal perforation and encephalopathy, require prompt recognition and management. Surgical intervention may be necessary for intestinal perforation. Encephalopathy and other neurological complications are managed supportively. It is essential to monitor patients closely for signs of complications, especially in the second week of illness.
Prevention and control of enteric fever are based on improving sanitation, providing access to clean water, and vaccination. Typhoid vaccines are recommended for people in high-risk areas and travelers to these areas. However, vaccines are not 100% effective, and hygiene measures remain crucial. Public health measures, including surveillance and prompt outbreak response, are also essential in controlling the spread of enteric fever.
Antimicrobial resistance is a growing concern in the management of enteric fever. Multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains have been reported. This underscores the importance of rational use of antimicrobials, susceptibility testing, and the development of new antimicrobials. It also highlights the need for effective vaccines and improved sanitation and hygiene to prevent the spread of resistant strains.
Enteric fever remains a significant global health problem, particularly in resource-limited settings. Effective management requires a high index of suspicion for early diagnosis, appropriate antimicrobial therapy, management of complications, and prevention and control measures. Antimicrobial resistance is a growing challenge, emphasizing the need for rational use of antimicrobials, development of new drugs, and preventive measures such as vaccination and improved sanitation. Healthcare professionals play a vital role in all these aspects of enteric fever management.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation